Informationen:
Fehler:
ID
21229
Beschreibung
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00601406
Link
https://clinicaltrials.gov/show/NCT00601406
Stichworte
Versionen (1)
- 13.04.17 13.04.17 -
Hochgeladen am
13. April 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00601406
Eligibility Breast Cancer NCT00601406
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00601406
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
curative radiotherapy in clinical study
Item
patients must have received curative external-beam radiotherapy within the context of a formal clinical study for any of the following:
boolean
C0008972 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
early breast cancer after breast-conserving surgery
Item
early breast cancer after breast-conserving surgery
boolean
C4016951 (UMLS CUI [1,1])
C0917927 (UMLS CUI [1,2])
C0917927 (UMLS CUI [1,2])
prostate cancer
Item
localized prostate cancer
boolean
C0600139 (UMLS CUI [1])
gynecological cancer, brachytherapy
Item
gynecological cancer (may have also received brachytherapy)
boolean
C0006826 (UMLS CUI [1,1])
C0017411 (UMLS CUI [1,2])
C0006098 (UMLS CUI [1,3])
C0017411 (UMLS CUI [1,2])
C0006098 (UMLS CUI [1,3])
venous blood samples available
Item
venous blood samples must be available
boolean
C0444255 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,2])
patient identification studies
Item
patients will be identified from the following clinical studies:
boolean
C0008972 (UMLS CUI [1,1])
C1269815 (UMLS CUI [1,2])
C1269815 (UMLS CUI [1,2])
radiotherapy to breast trial
Item
cambridge intensity-modulated radiotherapy breast randomized trial
boolean
C0008972 (UMLS CUI [1,1])
C0948310 (UMLS CUI [1,2])
C0948310 (UMLS CUI [1,2])
radiotherapy to prostate trial
Item
rt01 prostate radiotherapy randomized trial/other prostate trials
boolean
C0008972 (UMLS CUI [1,1])
C0948317 (UMLS CUI [1,2])
C0948317 (UMLS CUI [1,2])
radiotherapy to breast, prostate, gynecological cancer trial
Item
christie hospital breast, prostate, and gynecological cancer radiotherapy patients
boolean
C0008972 (UMLS CUI [1,1])
C0948310 (UMLS CUI [1,2])
C0948317 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0017411 (UMLS CUI [1,5])
C0006826 (UMLS CUI [1,6])
C0948310 (UMLS CUI [1,2])
C0948317 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0017411 (UMLS CUI [1,5])
C0006826 (UMLS CUI [1,6])
follow up available
Item
must have minimum follow up with late normal tissue effect scoring for two years available
boolean
C0589120 (UMLS CUI [1])
patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
other malignancies
Item
no other malignancy prior to treatment for the specified tumor types except basal cell or squamous cell carcinoma of the skin or in situ carcinoma
boolean
C0009488 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
disease characteristics
Item
see disease characteristics
boolean
C1705348 (UMLS CUI [1])